The Board of Directors of Livzon Pharmaceutical Group Inc. has authorized a buyback plan on October 30, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
38.98 CNY | -1.32% | +2.99% | +11.34% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.34% | 4.34B | |
+25.83% | 661B | |
+26.49% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.83% | 231B | |
+5.08% | 200B | |
-8.92% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 000513 Stock
- News Livzon Pharmaceutical Group Inc.
- Livzon Pharmaceutical Group Inc. authorizes a Buyback Plan.